Validation and Feasibility of Noninvasive Oxygen Delivery Index Monitoring in Cardiac Surgery Patients

StatusNot Yet Recruiting
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Start date: Oct 15, 2026 to Dec 15, 2026
    • Eligibility criteria expanded, about 7 words
    • Secondary endpoints: details revised at 6 of 6 entries
  2. Start date: Aug 15, 2026 to Oct 15, 2026v3
  3. Start date: Jul 1, 2026 to Aug 15, 2026v2
  4. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
This study will establish the feasibility and preliminary validity of real-time oxygen delivery index (DO₂i) monitoring using noninvasive hemoglobin (SpHb, Masimo) and minimally invasive cardiac output (FloTrac, Edwards) in cardiac surgery patients.
Trial Details
NCT Number NCT07573306
Lead Sponsor University of Minnesota
Conditions
(from sponsor)		 Cardiac Surgery
Enrollment 150 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov